Oncology - Pathology Dialogues: Evolving Diagnostic Pathways to Expand Treatment of Extrapulmonary Neuroendocrine Neoplasms
Please visit answersincme.com/KJW860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Aman Chauhan, MD and Rhonda K. Yantiss, MD. In this activity, experts in medical oncology and pathology discuss identification and treatment of extrapulmonary neuroendocrine carcinomas and extrapulmonary neuroendocrine tumors. Upon completion of this activity, participants should be better able to: Differentiate extrapulmonary neuroendocrine carcinoma (EP-NEC) from extrapulmonary neuroendocrine tumors (EP-NETs); Identify diagnostic and pathological approaches to improve the recognition and accurate classification of EP-NEC and EP-NET; Evaluate emerging clinical data on DLL3-targeting bispecific TCE agents in the treatment of EP-NEC and EP-NET; and Formulate evidence-based strategies to integrate DLL3-targeting bispecific TCE therapies into evolving treatment paradigms for EP-NEC and EP-NET.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from CME in Minutes: Education in Primary Care
It’s Not "Just Hives": Advancing Targeted Care in Chronic Spontaneous Urticaria
From Evidence to Impact: Leveraging the Latest Data to Elevate Standards and Patient Outcomes in mHSPC
Management of Overactive Bladder in Patients With Benign Prostatic Hyperplasia: Tailoring Treatment for Individualized Care
Translating Evidence Into Practice: Optimizing Chemotherapy-Free Intervals and Sequencing in mCRC
Get summaries like this every morning.
Free AI-powered recaps of CME in Minutes: Education in Primary Care and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.